Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Omega Funds is a leading international venture capital firm exclusively focused on the life sciences and healthcare sectors. Founded in 2004 by Otello Stampacchia, the firm specializes in creating and investing in companies that address urgent, unmet medical needs across the globe. Omega employs a stage-agnostic investment strategy that encompasses company creation, primary venture investing, direct secondaries, and public market investments. With approximately $2.5 billion in capital raised across eight funds, the firm has a prolific track record, with its portfolio companies having brought over 50 products to market. Omega Funds maintains a strong presence in both North America and Europe, leveraging a data-driven approach to identify and support transformative innovations in biotechnology.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Omega Advisors.